[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 274,516
  • Shares Outstanding, K 95,650
  • Annual Sales, $ 824,500 K
  • Annual Income, $ -365,900 K
  • EBIT $ -91 M
  • EBITDA $ 283 M
  • 60-Month Beta 1.69
  • Price/Sales 0.35
  • Price/Cash Flow 0.81
  • Price/Book 0.96

Options Overview Details

View History
  • Implied Volatility 101.73% (-97.45%)
  • Historical Volatility 189.22%
  • IV Percentile 20%
  • IV Rank 8.05%
  • IV High 586.89% on 02/19/26
  • IV Low 59.28% on 08/20/25
  • Expected Move (DTE 1) 0.11 (3.46%)
  • Put/Call Vol Ratio 6.20
  • Today's Volume 36
  • Volume Avg (30-Day) 175
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 5,104
  • Open Int (30-Day) 3,901
  • Expected Range 3.08 to 3.30

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.24
  • Number of Estimates 2
  • High Estimate $-0.24
  • Low Estimate $-0.24
  • Prior Year $-0.13
  • Growth Rate Est. (year over year) -84.62%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.74 +16.42%
on 08/03/26
6.19 -48.47%
on 07/20/26
-2.99 (-48.38%)
since 07/17/26
3-Month
2.74 +16.42%
on 08/03/26
6.43 -50.39%
on 07/16/26
-0.36 (-10.14%)
since 05/19/26
52-Week
2.74 +16.42%
on 08/03/26
8.59 -62.86%
on 10/16/25
-2.32 (-42.11%)
since 08/19/25

Most Recent Stories

More News
1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm

1 Small-Cap Stock with Promising Prospects and 2 That Underwhelm

MYGN : 3.19 (+11.15%)
EPAM : 107.37 (+7.10%)
CVSA : 131.93 (+0.36%)
MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations

The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Myriad Genetics, Inc. (“Myriad Genetics” or the “Company”) (NASDAQ: MYGN) investors concerning...

MYGN : 3.19 (+11.15%)
Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky

Myriad Genetics reported Q2 2026 revenue of approximately $190.7 million against consensus of roughly $206-208 million, then cut full-year revenue guidance by about $90 million at the midpoint and suspended...

MYGN : 3.19 (+11.15%)
3 Healthcare Stocks with Open Questions

3 Healthcare Stocks with Open Questions

MYGN : 3.19 (+11.15%)
GILD : 147.60 (+2.90%)
SHC : 19.00 (+2.65%)
MYGN Investors Have Opportunity to Join Myriad Genetics, Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Myriad Genetics, Inc. (“Myriad”...

MYGN : 3.19 (+11.15%)
MYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN)

Myriad Genetics showed investors an adjusted EBITDA target of $37 million to $49 million for 2026. Months later, the Company suspended adjusted EBITDA guidance entirely -- leaving MYGN shareholders to...

MYGN : 3.19 (+11.15%)
Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN)

On May 5, 2026, Myriad Genetics management reaffirmed full-year revenue of $860-$880 million. Just three months later, the Company cut guidance to $770-$790 million and adjusted EBITDA guidance was suspended...

MYGN : 3.19 (+11.15%)
Why Myriad Genetics (MYGN) Shares Are Falling Today

Why Myriad Genetics (MYGN) Shares Are Falling Today

MYGN : 3.19 (+11.15%)
Myriad Genetics (NASDAQ:MYGN) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 28.6%

Myriad Genetics (NASDAQ:MYGN) Reports Sales Below Analyst Estimates In Q2 CY2026 Earnings, Stock Drops 28.6%

MYGN : 3.19 (+11.15%)
Myriad: Q2 Earnings Snapshot

Myriad: Q2 Earnings Snapshot

MYGN : 3.19 (+11.15%)

Business Summary

Myriad Genetics employs a number of proprietary technologies to target the genetic basis of human diseases and the role these genes might play in the onset, progression and treatment of the respective diseases. The company has more than 10 proprietary molecular diagnostic products in market. It has made...

See More

Key Turning Points

3rd Resistance Point 3.56
2nd Resistance Point 3.38
1st Resistance Point 3.29
Last Price 3.19
1st Support Level 3.01
2nd Support Level 2.83
3rd Support Level 2.73

See More

52-Week High 8.59
Fibonacci 61.8% 6.36
Fibonacci 50% 5.66
Fibonacci 38.2% 4.97
Last Price 3.19
52-Week Low 2.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.